SPONSOR
Capital Medical University
Total Trials
4
Recruiting
4
Phases
Phase 1
Conditions studied: StrokeHypothermia TreatmentIschemic StrokeAtrial FibrillationAcute Ischemic StrokeBasilar Artery OcclusionMeningiomaCDK4/6 Inhibitor
Capital Medical University is a clinical research sponsor with 4 registered studies on ClinicalTrials.gov, of which 4 are actively recruiting participants. Research covers conditions including Stroke, Hypothermia Treatment, Ischemic Stroke, Atrial Fibrillation.
The trial portfolio spans Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Capital Medical University
How many clinical trials has Capital Medical University sponsored?
ClinicalMetric currently tracks 4 clinical trials sponsored by Capital Medical University, of which 4 are actively recruiting participants. These trials cover conditions including Stroke, Hypothermia Treatment, Ischemic Stroke. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Capital Medical University research focus on?
Capital Medical University clinical trials span Stroke, Hypothermia Treatment, Ischemic Stroke, Atrial Fibrillation, Acute Ischemic Stroke, and additional conditions. The research pipeline includes Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Capital Medical University clinical trial?
To participate in a Capital Medical University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Capital Medical University trials with current recruitment status updated daily.
Clinical Trials by Capital Medical University
NCT06665386
Recruiting
Prognostic Biomarkers for Selective Intra-Arterial Cooling Infusion Combined with Endovascular Thrombectomy in Acute Ischemic Stroke Based on Proteomics and Metabolomics.
Stroke
NCT07139314
Recruiting
Timing of Anticoagulation After Emergency Endovascular Therapy for Acute Ischemic Stroke With Atrial Fibrillation 2
Ischemic Stroke
NCT06560203
Recruiting
Basilar Artery Occlusion Chinese Endovascular Trial in the Extended Time Window
Acute Ischemic Stroke
NCT07652762 Phase 1
Recruiting
IN10018 in Combination With Dalpiciclib for Progressive Meningiomas
Meningioma
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology